We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NH
2976
DELISTED
NantHealth, Inc
NH
$48K ﹤0.01%
1,371
-9
-0.7% -$358
BLRX
2977
BioLineRX
BLRX
$12.5M
$38K ﹤0.01%
342
LFWD icon
2978
ReWalk Robotics
LFWD
$20.5M
$37K ﹤0.01%
262
GTE icon
2979
Gran Tierra Energy
GTE
$322M
$20K ﹤0.01%
2,738
ABEO icon
2980
Abeona Therapeutics
ABEO
$396M
-3,595
Closed -$169K
ACNB icon
2981
ACNB Corp
ACNB
$669M
-13,019
Closed -$381K
ADMA icon
2982
ADMA Biologics
ADMA
$2.32B
-64,698
Closed -$114K
CHGA
2983
Change Agents Corporation Common Stock
CHGA
$2.7M
-91
Closed -$15K
ALCO icon
2984
Alico
ALCO
$283M
-7,489
Closed -$224K
APT icon
2985
Alpha Pro Tech
APT
$53.6M
-15,631
Closed -$153K
AQST icon
2986
Aquestive Therapeutics
AQST
$478M
-18,815
Closed -$98K
ASC icon
2987
Ardmore Shipping
ASC
$693M
-52,672
Closed -$239K
ASMB icon
2988
Assembly Biosciences
ASMB
$529M
-3,593
Closed -$198K
ASPS icon
2989
Altisource Portfolio Solutions
ASPS
$65.8M
-1,301
Closed -$96K
ASUR icon
2990
Asure Software
ASUR
$249M
-17,087
Closed -$131K
ATLO icon
2991
AMES National
ATLO
$277M
-14,379
Closed -$368K
ATXS
2992
DELISTED
Astria Therapeutics
ATXS
-3,524
Closed -$61K
AYTU icon
2993
AYTU BioPharma
AYTU
$24.3M
-692
Closed -$105K
BCBP icon
2994
BCB Bancorp
BCBP
$162M
-24,103
Closed -$333K
BCLI
2995
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-1,882
Closed -$108K
BCML icon
2996
BayCom
BCML
$331M
-16,031
Closed -$289K
BFIN
2997
DELISTED
BankFinancial
BFIN
-21,718
Closed -$224K
BGSF icon
2998
BGSF Inc
BGSF
$60.4M
-15,184
Closed -$213K
BPRN icon
2999
Princeton Bancorp
BPRN
$287M
-9,291
Closed -$266K
STEX
3000
Streamex Corp
STEX
$74.5M
-1,921
Closed -$83K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.